1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Montero S, Rivas-Lasarte M, Huang F, Chommeloux J, Demondion P, Bréchot N, Hékimian G, Franchineau G, Persichini R, Luyt CÉ, Garcia-Garcia C, Bayes-Genis A, Lebreton G, Cinca J, Leprince P, Combes A, Alvarez-Garcia J, Schmidt M.

    Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shock

    ESC heart failure . 10(1): 568-577.

    [doi:10.1002/ehf2.14132]

  • Viana-Tejedor A, Andrea-Riba R, Scardino C, Ariza-Solé A, Bañeras J, García-García C, Jiménez Mena M, Vila M, Martínez-Sellés M, Pastor G, García Acuña JM, Loma-Osorio P, García Rubira JC, Jorge Pérez P, Pastor P, Ferrera C, Noriega FJ, Pérez Macías N, Fernández-Ortiz A, Pérez-Villacastín J.

    Coronary angiography in patients without ST-segment elevation following out-of- hospital cardiac arrest. COUPE clinical trial

    REVISTA ESPANOLA DE CARDIOLOGIA . 76(2): 94-102. Nº de citas: 11

    [doi:10.1016/j.recesp.2022.05.004]

  • Pedretti RFE, Hansen D, Ambrosetti M, Back M, Berger T, Ferreira MC, Cornelissen V, Davos CH, Doehner W, de Pablo Y Zarzosa C, Frederix I, Greco A, Kurpas D, Michal M, Osto E, Pedersen S, Salvador RE, Simonenko M, Steca P, Thompson DR, Wilhelm M, Abreu A.

    How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology

    European journal of preventive cardiology . 30(2): 149-166. Nº de citas: 14

    [doi:10.1093/eurjpc/zwac204]

  • Fernández-Calvillo MG, Goya-Esteban R, Cruz-Roldán F, Hernández-Madrid A, Blanco-Velasco M.

    Machine Learning approach for TWA detection relying on ensemble data design.

    Heliyon . 9(1): .

    [doi:10.1016/j.heliyon.2023.e12947]

  • Toledano Sanz P, Reventun P, Viskadourou M, Osburn WO, Alcharani N, Lowenstein C, Arvanitis M.

    The transcriptional landscape of human liver endothelial cells.

    Blood Advances . : .

    [doi:10.1182/bloodadvances.2022008818]

  • Castro-Pinto, M, Lopez-Menendez, J, Sanchez-Esteban, S, Hernandez, I, Reventun, P, Rodriguez-Roda, J, Zaragoza, C, Saura, M.

    Endothelial integrine-linked kinase and valvular calcification: Molecular studyof calcification in aortic valve

    Cirugia Cardiovascular . 30(1): 11-16.

    [doi:10.1016/j.circv.2022.07.002]

  • Shuvy M, von Bardeleben RS, Grasso C, Raake P, Lurz P, Zamorano JL, Asch F, Kar S, Maisano F.

    Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study.

    ESC heart failure . 10(2): 1122-1132.

    [doi:10.1002/ehf2.14273]

  • Lee GA, Aktaa S, Baker E, Gale CP, Israa Fadhil Y, Gulati G, Asteggiano R, Szmit S, Cohen-Solal A, Abdin A, Jurczak W, Garrido Lopez P, Sverdlov AL, Tocchetti CG, Barac A, Parrini I, Zamorano P, Iakobishvili Z, Pudil R, Badimon L, Kirby AM, Blaes AH, Farmakis D, Curigliano G, Stephens R, Lyon AR, Lopez-Fernandez T.

    European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment

    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES . 9(1): 1-7. Nº de citas: 4

    [doi:10.1093/ehjqcco/qcac070]

  • Díaz Del Campo LS, García-Redondo AB, Rodriguez C, Zaragoza C, Duro-Sánchez S, Palmas F, de Benito-Bueno A, Socuéllamos PG, Peraza DA, Rodrigues-Diez R, Valenzuela C, Dalli J, Salaices M, Briones AM.

    Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin Ii-Induced Hypertension.

    Hypertension . 80(1): 84-96.

    [doi:10.1161/HYPERTENSIONAHA.122.19448]

  • Lund LH, Zeymer U, Clark AL, Barrios V, Damy T, Drozdz J, Fonseca C, Kalus S, Ferber PC, Koch C, Maggioni AP.

    Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 370: 279-286.

    [doi:10.1016/j.ijcard.2022.10.012]

  • Salido Tahoces L, Fernández Golfín C, Sánchez Recalde A, Pardo Sanz A, Zamorano Gómez JL.

    No matter how big it is: 3D tools for giant atrial appendage closure.

    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 24(3): 42-42.

    [doi:10.1093/ehjci/jeac257]

  • Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Fernández MS, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Pérez-Cabeza AI, Rodríguez JMV, Priu CR, Sánchez MA, Lip GYH, Marin F.

    Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.

    European heart journal. Cardiovascular pharmacotherapy . 9(1): 38-46.

    [doi:10.1093/ehjcvp/pvac060]

  • Lorente-Ros Á, Alonso-Salinas GL, Monteagudo Ruiz JM, Abellás-Sequeiros M, Vieítez-Florez JM, Sánchez Vega D, Álvarez-Garcia J, Sanmartín-Fernández M, Lorente-Ros M, Del Prado Díaz S, Fernández Golfín C, Zamorano Gómez JL.

    Effect of Duration of Anticoagulation in the Incidence of Stroke in Patients With Left-Ventricular Thrombus.

    AMERICAN JOURNAL OF CARDIOLOGY . 185: 115-121. Nº de citas: 3

    [doi:10.1016/j.amjcard.2022.09.005]

  • Nadarajah R, Ludman P, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP.

    Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry.

    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES . 9(1): 8-15.

    [doi:10.1093/ehjqcco/qcac067]

  • Anguita Sánchez M, Marín F, Masjuan J, Cosín-Sales J, Vázquez Rodríguez JM, Barrios V, Barón-Esquivias G, Lekuona I, Pérez-Cabeza AI, Freixa-Pamias R, Parra Jimenez FJ, Monzer Khanji Khatib M, Rafols Priu C, Sanmartín Fernández M.

    Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

    CARDIOLOGY JOURNAL . 29(6): 936-947. Nº de citas: 1

    [doi:10.5603/CJ.a2022.0091]

  • Lozano-Granero C, Franco E, Matía-Francés R, Hernández-Madrid A, Sánchez-Pérez I, Zamorano JL, Moreno J.

    Characterization of high-power and very-high-power short-duration radiofrequency lesions performed with a new-generation catheter and a temperature-control ablation mode

    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY . 33(12): 2528-2537. Nº de citas: 1

    [doi:10.1111/jce.15676]

  • Maggioni AP, Clark AL, Barrios V, Damy T, Drozdz J, Fonseca C, Lund LH, Kalus S, Ferber PC, Hussain RI, Koch C, Zeymer U.

    Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry

    ESC heart failure . 9(6): 4209-4218. Nº de citas: 3

    [doi:10.1002/ehf2.14014]

  • García Martín A, Abellás Sequeiros M, González Gómez AG, Rincón Díaz LM, Monteagudo Ruiz JM, Hinojar Baydés R, Moya Mur JL, Zamorano JL, Fernández-Golfín C.

    Prognostic value of diastolic function parameters in significant aortic regurgitation: the role of the left atrial strain.

    Journal of Echocardiography . 20(4): 216-223.

    [doi:10.1007/s12574-022-00577-6]